VIMAB Group Financials
| VIMAB Stock | 7.90 0.05 0.63% |
VIMAB |
Understanding current and past VIMAB Group Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of VIMAB Group's financial statements are interrelated, with each one affecting the others. For example, an increase in VIMAB Group's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in VIMAB Group's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of VIMAB Group AB. Check VIMAB Group's Beneish M Score to see the likelihood of VIMAB Group's management manipulating its earnings.
| Instrument | Sweden Stock View All |
| Exchange | Stockholm Exchange |
| ISIN | SE0007439633 |
| Business Address | BjOernvAegen 6, Motala, |
| Sector | Industrials |
| Industry | Consulting Services |
| Benchmark | Dow Jones Industrial |
| Website | www.vimabgroup.com |
| Phone | 46 8 458 53 50 |
You should never invest in VIMAB Group without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of VIMAB Stock, because this is throwing your money away. Analyzing the key information contained in VIMAB Group's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
VIMAB Group Key Financial Ratios
There are many critical financial ratios that VIMAB Group's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that VIMAB Group AB reports annually and quarterly.VIMAB Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining VIMAB Group's current stock value. Our valuation model uses many indicators to compare VIMAB Group value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across VIMAB Group competition to find correlations between indicators driving VIMAB Group's intrinsic value. More Info.VIMAB Group AB is rated first in return on equity category among its peers. It is rated first in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the VIMAB Group's earnings, one of the primary drivers of an investment's value.VIMAB Group AB Systematic Risk
VIMAB Group's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. VIMAB Group volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on VIMAB Group AB correlated with the market. If Beta is less than 0 VIMAB Group generally moves in the opposite direction as compared to the market. If VIMAB Group Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one VIMAB Group AB is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of VIMAB Group is generally in the same direction as the market. If Beta > 1 VIMAB Group moves generally in the same direction as, but more than the movement of the benchmark.
VIMAB Group November 28, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of VIMAB Group help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of VIMAB Group AB. We use our internally-developed statistical techniques to arrive at the intrinsic value of VIMAB Group AB based on widely used predictive technical indicators. In general, we focus on analyzing VIMAB Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build VIMAB Group's daily price indicators and compare them against related drivers.
| Downside Deviation | 7.07 | |||
| Information Ratio | 0.0471 | |||
| Maximum Drawdown | 139.98 | |||
| Value At Risk | (10.98) | |||
| Potential Upside | 7.53 |
Additional Tools for VIMAB Stock Analysis
When running VIMAB Group's price analysis, check to measure VIMAB Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VIMAB Group is operating at the current time. Most of VIMAB Group's value examination focuses on studying past and present price action to predict the probability of VIMAB Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VIMAB Group's price. Additionally, you may evaluate how the addition of VIMAB Group to your portfolios can decrease your overall portfolio volatility.